Akari Therapeutcis (AKTX) Reports In-Line Q1 EPS

Akari Therapeutcis (NASDAQ: AKTX) reported Q1 EPS of $0.00.

For earnings history and earnings-related data on Akari Therapeutcis (AKTX) click here.

You May Also Be Interested In

• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Nlight (LASR) Reiterated at Buy by Stifel: Sell-off is a 'Buying Opportunity'
• Circle8 Group posts record $569.7M first-half revenue, reports net loss